​
​

Foghorn Therapeutics Ownership | Who Owns Foghorn Therapeutics?

OverviewForecastRevenueFinancialsChart

Foghorn Therapeutics Ownership Summary

Foghorn Therapeutics is owned by 92.96% institutional investors, 18.98% insiders. Flagship pioneering is the largest institutional shareholder, holding 29.87% of FHTX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.76% of its assets in Foghorn Therapeutics shares.

FHTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockFoghorn Therapeutics92.96%18.98%-11.95%
SectorHealthcare Stocks 47.31%8.01%44.69%
IndustryBiotech Stocks 45.43%7.81%46.75%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Flagship pioneering12.67M29.87%$72.88M
Fmr6.38M15.04%$36.70M
Bvf inc/il5.30M12.50%$30.49M
Deerfield management company, l.p. (series c)2.52M5.94%$14.48M
Raymond james & associates2.34M5.51%$13.45M
Euclidean capital1.57M3.71%$9.05M
Blackrock1.55M3.64%$8.89M
Vanguard group1.06M2.50%$6.09M
Artal group720.72K1.70%$4.14M
Geode capital management531.11K1.25%$3.05M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Flagship pioneering12.67M8.64%$72.88M
Birchview capital, lp320.93K1.71%$1.85M
Euclidean capital1.57M1.14%$9.05M
Bvf inc/il5.30M0.85%$30.49M
Deerfield management company, l.p. (series c)2.52M0.24%$14.48M
Sio capital management121.67K0.19%$699.61K
Alphabet500.90K0.15%$2.88M
Artal group720.72K0.11%$4.14M
Alta wealth advisors30.03K0.09%$172.68K
Rockwood wealth management107.33K0.08%$617.14K

Top Buyers

HolderShares% AssetsChange
Bvf inc/il5.30M0.85%5.30M
Fmr6.38M0.00%3.69M
Deerfield management company, l.p. (series c)2.52M0.24%2.52M
Blackrock1.55M0.00%230.70K
Raymond james & associates2.34M0.01%107.97K

Top Sellers

HolderShares% AssetsChange
Driehaus capital management---568.47K
Perceptive advisors---544.00K
Colony group---215.69K
Invesco---56.04K
Vanguard group1.06M0.00%-43.01K

New Positions

HolderShares% AssetsChangeValue
Bvf inc/il5.30M0.85%5.30M$30.49M
Deerfield management company, l.p. (series c)2.52M0.24%2.52M$14.48M
Bridgeway capital management57.50K0.01%57.50K$330.63K
Wellington management group llp43.79K-43.79K$251.79K
Dafna capital management41.85K0.06%41.85K$240.64K

Sold Out

HolderChange
Zurcher kantonalbank (zurich cantonalbank)-2.00
Nelson, van denburg & campbell wealth management group-3.00
Group one trading-151.00
Visionpoint advisory group-210.00
Capital analysts-547.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2024735.80%39,443,56549.07%922.37%3835.71%16-11.11%
Mar 31, 20246916.95%26,459,8101.01%621.61%2816.67%185.88%
Dec 31, 202359-3.28%26,194,106-2.71%621.50%2426.32%17-10.53%
Sep 30, 2023611.67%26,924,9370.60%641.57%19-24.00%1926.67%
Jun 30, 202360-4.76%26,763,7561.94%641.62%258.70%15-6.25%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S2.63M4.76%14.36K
Fidelity Growth Compy Commingled Pl O2.62M4.73%-
Fidelity Growth Company Fund1.90M3.44%-4.04K
Vanguard Total Stock Mkt Idx Inv962.18K1.74%-
Fidelity Select Biotechnology751.94K1.36%-155.50K
iShares Russell 2000 ETF618.26K1.11%-1.39K
Fidelity Growth Company K6598.20K1.08%-10.32K
Vanguard Institutional Extnd Mkt Idx Tr519.59K0.94%233.33K
Fidelity Series Growth Company445.41K0.81%-
Fidelity Small Cap Index262.88K0.48%-2.86K

Recent Insider Transactions

DateNameRoleActivityValue
Sep 23, 2024Costa Carlos Chief People OfficerSell$8.72K
Sep 20, 2024Costa Carlos Chief People OfficerSell$358.99K
Sep 18, 2024Costa Carlos Chief People OfficerSell$116.32K
Sep 16, 2024Costa Carlos Chief People OfficerSell$4.00K
Sep 17, 2024Costa Carlos Chief People OfficerSell$103.13K

Insider Transactions Trends

DateBuySell
2024 Q3-6
2024 Q22-
2024 Q1-1
2023 Q4--
2023 Q3-1

FHTX Ownership FAQ

Who Owns Foghorn Therapeutics?

Foghorn Therapeutics shareholders are primarily institutional investors at 92.96%, followed by 18.98% insiders and -11.94% retail investors. The average institutional ownership in Foghorn Therapeutics's industry, Biotech Stocks , is 45.43%, which Foghorn Therapeutics exceeds.

Who owns the most shares of Foghorn Therapeutics?

Foghorn Therapeutics’s largest shareholders are Flagship pioneering (12.67M shares, 29.87%), Fmr (6.38M shares, 15.04%), and Bvf inc/il (5.3M shares, 12.50%). Together, they hold 57.41% of Foghorn Therapeutics’s total shares outstanding.

Does Blackrock own Foghorn Therapeutics?

Yes, BlackRock owns 3.64% of Foghorn Therapeutics, totaling 1.55M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 8.89M$. In the last quarter, BlackRock increased its holdings by 230.7K shares, a 17.54% change.

Who is Foghorn Therapeutics’s biggest shareholder by percentage of total assets invested?

Flagship pioneering is Foghorn Therapeutics’s biggest shareholder by percentage of total assets invested, with 8.64% of its assets in 12.67M Foghorn Therapeutics shares, valued at 72.88M$.

Who is the top mutual fund holder of Foghorn Therapeutics shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Foghorn Therapeutics shares, with 4.76% of its total shares outstanding invested in 2.63M Foghorn Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools